News

Deepseek AI’s scare kicked off the year, rattling faith in the “Magnificent Seven” and the broader tech space. 💵💰Don't miss ...
In adults with obesity and prediabetes, weight loss achieved with tirzepatide was sustained at more than 3 years, according ...
With semaglutide and tirzepatide dosed once weekly, their estimated average yearly costs in the U.S. are $14,080 and $8,126, ...
Prescriptions for tirzepatide injections will not be available from GP surgeries or pharmacies in East and North Yorkshire – ...
WEIGHT loss jabs may also help ward off dementia, a new study suggests. Researchers found that semaglutide – the active ...
Novo Nordisk launches Wegovy in India, expanding GLP-1 obesity drug market. The product competes with Eli Lilly's Mounjaro ...
The growing popularity of weight loss jabs could be affecting shopping habits in UK supermarkets, a leading research group ...
GPs in England will be able to prescribe weight loss jabs for the first time on the NHS on Monday, as the health service ...
Danish drugmaker Novo Nordisk has launched its popular weight-loss drug Wegovy in India, months after its rival Mounjaro’s ...
What happens if you stop GLP-1 weight loss injections like semaglutide and tirzepatide? Dr Bernard Tan from Bay Medical ...
Prescriptions for the weight-loss jab Mounjaro are now being offered at GP surgeries in England - but only for patients who ...
Infection, delayed kidney function, kidney loss and death are all risks associated with kidney transplant surgery in obese ...